[{"NetIncomeLossConverted_4_FY_USD":859100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":180804000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":85365000.0,"EarningsPerShareDiluted_4_FY_USD":4.53,"CommonStockSharesOutstanding_0_FY_shares":181740999.0,"StockholdersEquity_0_FY_USD":4106002000.0,"RevenuesConverted_4_FY_USD":1860455000.0,"Assets_0_FY_USD":5848020000.0,"CommonStockSharesConverted_0_FY_shares":181740999.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":191678000.0,"EarningsPerShareBasic_4_FY_USD":4.75,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210226"}]